MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Lack of Toll-like receptor 4 is associated with accumulation of alpha-synuclein in the midbrain Parkinson’s disease mice.

C. Conte, G. Mariucci, R. Cafaro (Perugia, Italy)

Meeting: 2022 International Congress

Abstract Number: 1354

Keywords: 1-Methyl-4-phenylpyridinium (MPP+), Alpha-synuclein, Substantia nigra pars compacta(SNpc)

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: In this study we aimed to investigate the potential role of Toll-like receptor 4 (TLR4) in mediating both the dopaminergic neuron loss and alpha-synuclein (alpha-SYN) accumulation in a mouse model of Parkinson’s disease (PD). To do this we used WT and TLR4-deficient mice (TLR4-/-).

Background: TLRs predominantly contribute to immune-related disorders.  However, new evidences suggest that neuronal TLR activation participates in the pathogenesis of neurodegenerative synucleinpathies, including PD. TLR4 dysregulation is thought to correlate with neurodegeneration and brain injury.

Method: WT and TLR4-/- mice were exposed to the acute1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) regimen. Mice (n=5 per group) received four i.p. injections at 2-h intervals. Seven days post-MPTP intoxication, mice were sacrificed by cervical dislocation and several brain regions were isolated. Immunohistochemistry, western immunoblotting, and real time PCR were performed to analyze the tyrosine hydroxylase (TH), alpha-SYN, and GATA-binding factor 2 (GATA2) transcription factor.

Results: We showed that TLR4 ablation contributes to restrain the depletion of striatal dopamine levels as well as the loss of TH+neurons and TH protein levels in the substantia nigra pars compacta (SNpc). Interestingly, we found that TLR4-null mice exhibited massive accumulation of alpha-SYN protein in the midbrain and high levels of alpha-SYN mRNA in different brain regions, such as cerebral cortex, cerebellum, striatum and hippocampus. In attempt to explore the mechanism that regulates the nigral alpha-SYN expression, the role of GATA2 transcription factor was investigated. Our data showed that the high levels of nigral alpha-SYN in TLR4-/- mice were not associated with increased levels of GATA2 protein expression.

Conclusion: Although preliminary, these results strongly suggest an important role of TLR4 in mediating dopaminergic cell loss and alpha-SYN overexpression and accumulation. Synergistic mechanisms deserve to be further investigated.

To cite this abstract in AMA style:

C. Conte, G. Mariucci, R. Cafaro. Lack of Toll-like receptor 4 is associated with accumulation of alpha-synuclein in the midbrain Parkinson’s disease mice. [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/lack-of-toll-like-receptor-4-is-associated-with-accumulation-of-alpha-synuclein-in-the-midbrain-parkinsons-disease-mice/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/lack-of-toll-like-receptor-4-is-associated-with-accumulation-of-alpha-synuclein-in-the-midbrain-parkinsons-disease-mice/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley